does tirzepatide make you throw up Side Effects: Common & Rare Reactions Explained How should I manage a

The mice in the intervention group received subcutaneous injections of tirzepatide (Eli Lilly and Company, Indianapolis, Indiana) with dose escalation: initially, 0.03 mg/kg for the first 4 weeks, followed by 0.1 mg/kg for the subsequent 4 weeks, culminating at 0.3 mg/kg for the final 4 weeks, with administrations twice weekly

This article explores how GLP-1 use is reshaping visit cadence and what clinicians should consider when determining optimal follow-up strategies

Novel long non-coding RNAs of relevance for ulcerative colitis pathogenesis

Approximately 20% of the US gastroenterologists and primary care providers most of the time or always recommend antidepressants for IBS-D and IBS-C 9